Mou S, Zhou M, Li Y, Wang J, Yuan Q, Xiao P, Sun J, Wang Z
Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: Incidence and consequences
GLP- 1 receptor agonists have a mechanism of action that provides a multimodal strategy for the treatment of obesity and T2DM
In addition, the effects of estrogen are also influenced by how much an estrogen steroid hormone called serum estradiol (E2) is in the bloodstream
To nie chwilowy trend, lecz trwaa zmiana w podejciu do prewencji kardiometabolicznej.
This is why a diverse routine is often more effective than focusing on just one ingredient